You just read:

ReNeuron Announces Presentation of Updated Efficacy and Safety Data from Retinitis Pigmentosa Study at the Sixth Annual Retinal Cell and Gene Therapy Innovation Summit

News provided by

ReNeuron Group plc

Apr 26, 2019, 07:00 ET